Siddhartha Mukherjee

Columbia University Irving Medical Center — United States

Medicine · Health Sciences

45h-index10.2kcitations218works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(30), Chemical Reactions and Isotopes(27), Tryptophan and brain disorders(22), Multiple Myeloma Research and Treatments(20), Bone health and treatments(15)

Publications218 total

Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition
Nature Communications·2025· 1 citedOpen Access
Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy
Nature Communications·2025· 8 citedOpen Access
Multi-node inhibition targeting mTORC1, mTORC2 and PI3Kα potently inhibits the PI3K/AKT/mTOR pathway in endometrial and breast cancer models
British Journal of Cancer·2025· 5 citedOpen Access
Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids
Journal of Medicinal Chemistry·2025· 3 cited
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
UNC Libraries·2025Open Access
A Systematic Review of the Prevalence of Overactive Bladder in Women with Non-Urinary Tract Endometriosis and the Effect of Endometriosis Surgery on Symptoms of Overactive Bladder
International Urogynecology Journal·2024· 3 cited
Supply response of major oilseeds in India: A mix of price and non-price factors
Journal of Applied and Natural Science·2024· 1 citedOpen Access
Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia
UNC Libraries·2024Open Access
Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP-inhibition
2024Open Access
Abstract 3612: Preclinical & clinical activity of autologous mRNA engineered chimeric antigen receptor monocytes for targeted cancer immunotherapy
Cancer Research·2024· 1 cited
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity
Molecular Therapy — Methods & Clinical Development·2023· 3 citedOpen Access
Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis
Nature Communications·2023· 33 citedOpen Access
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity
Molecular Therapy — Methods & Clinical Development·2023· 16 citedOpen Access
E-223 Improved time to diagnosis with portable MR imaging
2023Open Access
Abstract CT131: Initial preclinical and clinical experience of autologous engineered monocytes in T cell lymphoma patients
Cancer Research·2023· 2 cited
Abstract 3399: Tumor organoid based drug sensitivity testing in ovarian cancer identifies exceptional responders to targeted therapies
Cancer Research·2023
Supplementary Table from Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia
2023Open Access
Supplementary Figure from Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia
2023Open Access
Supplementary Data from Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia
2023Open Access
Supplementary Figure from Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Daniel L. Worthley(9), David T. Scadden(8), Michael Churchill(7), Azra Raza(7), Jesse Schoonmaker(6), Timothy C. Wang(6), Noopur Raje(6), Teru Hideshima(6), Sonia Vallet(6), Samantha Pozzi(6), Kenneth C. Anderson(6), Abdullah Mahmood Ali(6), Susan L. Woods(6), Yoku Hayakawa(5), Yen K. Lieu(5), Diana Cirstea(5), Hiroki Kobayashi(5), Tamsin R.M. Lannagan(5), Tongtong Wang(5), Laura Vrbanac(5)